U.S. stock futures mixed, Dow up 100 points. SpaceX stock falls 10.3% after reporting strong Q2 revenue but a loss. Other stocks also decline.

U.S. stock futures higher, AstraZeneca dips on merger talks, Apple down 7.4%, other stocks moving lower in pre-market trading.

SpaceX (SPCX) trades down near $107 ahead of debut earnings. Wall Street holds a Buy rating with a consensus $229.96 price target.

Dow Poised to Break Winning Streak